TargetedOnc articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.targetedonc.com/articles TargetedOnc articles TargetedOnc articles en-us Sun, 21 Sep 2014 10:05:19 EDT 5 TargetedOnc articles 144 47 http://www.targetedonc.com/articles http://www.targetedonc.com/_media/_core/mainLogo.png <![CDATA[SIR-Spheres Microspheres for the Treatment of Liver Mets From CRC: Results of the SIRFLOX Trial Eagerly Anticipated]]>http://www.targetedonc.com/publications/targeted-therapies-cancer/2014/august-2014/SIR-Spheres-Microspheres-for-the-Treatment-of-Liver-Mets-FromCRC-Results-of-the-SIRFLOX-Trial-Eagerly-AnticipatedTargetedOnc articlesusFri, 19 Sep 2014 16:45:18 EDTTargetedOnc<![CDATA[Q & A With Tomasz M. Beer, MD: The Expanded Approval of Enzalutamide for mCRPC]]>http://www.targetedonc.com/articles/Q-and-A-with-Tomasz-M-Beer-MD-The-Expanded-Approval-of-Enzalutamide-for-mCRPCTargetedOnc articlesusThu, 18 Sep 2014 16:56:45 EDTTargetedOnc<![CDATA[Inducing an Immune Response With a Patient’s Tumor]]>http://www.targetedonc.com/publications/special-reports/2014/melanoma-skincancers-issue3/Inducing-an-Immune-Response-With-a-Patients-TumorTargetedOnc articlesusWed, 17 Sep 2014 20:28:24 EDTTargetedOnc<![CDATA[Resistance in Melanoma May Be Addressed With MAPK Inhibitors and Immunotherapies]]>http://www.targetedonc.com/publications/special-reports/2014/melanoma-skincancers-issue3/Resistance-in-Melanoma-May-Be-Addressed-With-MAPK-Inhibitors-and-ImmunotherapiesTargetedOnc articlesusWed, 17 Sep 2014 20:26:35 EDTTargetedOnc<![CDATA[Partnering T-VEC With a Targeted Agent for the Treatment of Melanoma]]>http://www.targetedonc.com/publications/special-reports/2014/melanoma-skincancers-issue3/Partnering-T-VEC-With-a-Targeted-Agent-for-the-Treatment-of-MelanomaTargetedOnc articlesusWed, 17 Sep 2014 20:24:44 EDTTargetedOnc<![CDATA[Challenges Apparent With Current Targeted Therapies for BRAF Metastatic Melanoma]]>http://www.targetedonc.com/publications/special-reports/2014/melanoma-skincancers-issue3/Challenges-Apparent-With-Current-Targeted-Therapies-for-BRAF-Metastatic-MelanomaTargetedOnc articlesusWed, 17 Sep 2014 20:15:54 EDTTargetedOnc<![CDATA[Immunotherapy Combinations for the Treatment of Melanoma]]>http://www.targetedonc.com/publications/special-reports/2014/melanoma-skincancers-issue3/Immunotherapy-Combinations-for-the-Treatment-of-MelanomaTargetedOnc articlesusWed, 17 Sep 2014 20:10:01 EDTTargetedOnc<![CDATA[Surveillance and Digital Dermoscopy Improve Accuracy of Melanoma Diagnosis]]>http://www.targetedonc.com/publications/special-reports/2014/melanoma-skincancers-issue3/Surveillance-and-Digital-Dermoscopy-Improve-Accuracy-of-Melanoma-DiagnosisTargetedOnc articlesusWed, 17 Sep 2014 14:49:01 EDTTargetedOnc<![CDATA[New Strategies Revealed in the Diagnosis of High Mitotic Rate Cutaneous Melanoma]]>http://www.targetedonc.com/publications/special-reports/2014/melanoma-skincancers-issue3/New-Strategies-Revealed-in-the-Diagnosis-of-High-Mitotic-Rate-Cutaneous-MelanomaTargetedOnc articlesusWed, 17 Sep 2014 14:47:58 EDTTargetedOnc<![CDATA[Low-Risk Stage IV NSCLC Patients Achieve Long-Term Survival After Aggressive Treatment]]>http://www.targetedonc.com/conference/astro-2014/Low-Risk-Stage-IV-NSCLC-Patients-Achieve-Long-Term-Survival-After-Aggressive-TreatmentTargetedOnc articlesusWed, 17 Sep 2014 11:42:15 EDTTargetedOnc a Targeted Oncology